CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishSARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support. ASAIO Journal 2020; 66:734-738.
| Titolo: | Veno-venous extracorporeal membrane oxygenation support in covid-19 respiratory distress syndrome: Initial experience | |
| Autore/i: | Loforte A.; Dal Checco E.; Gliozzi G.; Benedetto M.; Cavalli G. G.; Mariani C.; Piccone G.; Agulli M.; Pacini D.; Baiocchi M. | |
| Autore/i Unibo: | ||
| Anno: | 2020 | |
| Rivista: | ||
| Digital Object Identifier (DOI): | http://dx.doi.org/10.1097/MAT.0000000000001198 | |
| Abstract: | SARS-CoV-2 may cause severe respiratory failure due to massive alveolar damage. Currently, no adequate curative therapy for Coronavirus Disease 2019 (COVID-19) disease exists. By considering overall impact of COVID-19 pandemic outbreak, an increased need of extracorporeal membrane oxygenation (ECMO) support becomes evident. We report on our preliminary institutional experience with COVID-19 patients receiving venovenous ECMO support. ASAIO Journal 2020; 66:734-738. | |
| Data stato definitivo: | 2021-02-25T10:24:47Z | |
| Appare nelle tipologie: |
File in questo prodotto:
Copyright © 2022